ICON plc issued $2.15 billion of senior unsecured notes, comprising $500 million at 5.064% due 2029, $1.0 billion at 5.421% due 2031, and $650 million at 5.995% due 2036. The company used the net proceeds to repay a $900 million senior secured term loan, redeem $750 million of May 2027 notes, and retire a $500 million bridge facility. This refinancing triggered a $12.2 million loss on extinguishment of debt and released collateral securing other borrowings. Separately, the board increased the share repurchase authorization to $750 million following $400 million in buybacks during the third quarter. ICON plc is a global contract research organization providing outsourced clinical development services.
